SFCM
SLN

Seven Fleet Capital Management’s Silence Therapeutics SLN Stock Holding History

Seven Fleet Capital Management’s Portfolio SLN Stock Details SLN Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2026
Q2 		$660K Sell
60,107
-96,652
-62% -$680K 0.11% 69
2026
Q1 		$826K Buy
156,759
+9,159
+6% +$50.4K 0.26% 68
2025
Q4 		$897K Buy
+147,600
New +$945K 0.61% 31

Other funds holding SLN

SL
Siren LLC Greenwich, Connecticut $4.94B AUM 244.43% 1-Year Est. Return
TCM
TCG Crossover Management Palo Alto, California $4.16B AUM 983.43% 1-Year Est. Return
RG
Redmile Group San Francisco, California $1.49B AUM 208.7% 1-Year Est. Return
NCM
Nantahala Capital Management New Canaan, Connecticut $3.01B AUM 119.46% 1-Year Est. Return
Citadel Advisors
Citadel Advisors Miami, Florida $875B AUM 40.89% 1-Year Est. Return
NI
Nextech Invest Zurich, Switzerland $2.11B AUM 413.84% 1-Year Est. Return
Millennium Management
Millennium Management New York $276B AUM 44.8% 1-Year Est. Return
TAM
TFG Asset Management Grand Cayman, Cayman Islands $635M AUM 28.07% 1-Year Est. Return
SCM
Soleus Capital Management Greenwich, Connecticut $2.9B AUM 169.69% 1-Year Est. Return
Balyasny Asset Management
Balyasny Asset Management Chicago, Illinois $80.2B AUM 51.53% 1-Year Est. Return

Seven Fleet Capital Management's SLN Position: Q2 2026 in Review

Seven Fleet Capital Management reduced its Silence Therapeutics (SLN) stake by 62% in Q2 2026, selling an estimated $680K and leaving 60,107 shares worth $660K. The position accounts for 0.11% of the portfolio, ranked #69.

Seven Fleet Capital Management first reported a position in SLN in Q4 2025 and has held it in 3 quarters since. The position peaked at $897K in Q4 2025. 72 funds tracked by Wall St. Rank hold SLN as of Q2 2026.

  • Seven Fleet Capital Management held 60,107 shares of Silence Therapeutics worth $660K as of Q2 2026.
  • Seven Fleet Capital Management sold 96,652 Silence Therapeutics shares in Q2 2026, an estimated $680K.
  • Silence Therapeutics made up 0.11% of Seven Fleet Capital Management's portfolio in Q2 2026, its #69 holding.
  • Seven Fleet Capital Management first reported a position in Silence Therapeutics in Q4 2025 and has held it in 3 quarters since.
  • Seven Fleet Capital Management's Silence Therapeutics position peaked at $897K in Q4 2025.
  • 72 funds tracked by Wall St. Rank held Silence Therapeutics as of Q2 2026.

Based on Seven Fleet Capital Management's 13F filing for Q2 2026, filed 17 Aug 2026.